Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection.

导出 OA

翻译打印收藏纠错

作者： Victor,Manuylov ^[1] ; Olga,Burgasova ^[2] ; Olga,Borisova ^[1] ; Svetlana,Smetanina ^[3] ; Daria,Vasina ^[4] ; Igor,Grigoriev ^[5] ; Alexandra,Kudryashova ^[1] ; Maria,Semashko ^[1] ; Bogdan,Cherepovich ^[4] ; Olga,Kharchenko ^[1] ; Denis,Kleymenov ^[4] ; Elena,Mazunina ^[4] ; Artem,Tkachuk ^[1] ; Vladimir,Gushchin ^[1]

作者单位： Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia. ^[1] MedipalTech LLC, 141981 Dubna, Russia. ^[2] Medical Institute, Peoples Friendship University of Russia (RUDN University), 117198 Moscow, Russia. ^[3] Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia. ^[4] Infectious Disease Clinical Hospital № 1, 125367 Moscow, Russia. ^[5]

关键词 COVID-19 reinfection IgG avidity SARS-CoV-2

主题词抗体亲和力(Antibody Affinity);人类(Humans);免疫球蛋白G(Immunoglobulin G);预后(Prognosis)

DOI 10.3390/v14030617

PMID 35337024

发布时间 2023-03-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交